financetom
Business
financetom
/
Business
/
Ares Management Insider Sold Shares Worth $82,605,017, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ares Management Insider Sold Shares Worth $82,605,017, According to a Recent SEC Filing
Sep 8, 2025 12:28 AM

03:09 AM EDT, 09/08/2025 (MT Newswires) -- Antony P Ressler, 10% Owner, Director, Co-Founder & Executive Chairman, on September 03, 2025, sold 464,939 shares in Ares Management ( ARES ) for $82,605,017. Following the Form 4 filing with the SEC, Ressler has control over a total of 2,636,203 Class A common shares of the company, with 2,636,203 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1176948/000102597825000013/xslF345X05/wk-form4_1757119060.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Concentra Group Holdings Parent, Inc IPOs Tomorrow, Here's What You Need To Know
Concentra Group Holdings Parent, Inc IPOs Tomorrow, Here's What You Need To Know
Jul 24, 2024
Concentra Group Holdings Parent, Inc IPO will take place July, 25 on the NYSE exchange under the ticker CON. The company is offering shares at an expected price between $23.00 and $26.00 per share with an insider lock-up period of 180 days ending on January 21, 2025. See also: Benzinga IPO Calendar About Concentra Group Holdings Parent, Inc Concentra Group...
Sage, Biogen Shelve Development Of Nervous System Disorder Drug After Data Disappoints
Sage, Biogen Shelve Development Of Nervous System Disorder Drug After Data Disappoints
Jul 24, 2024
Sage Therapeutics Inc. ( SAGE )  and Biogen Inc. ( BIIB )  announced results Wednesday from the Phase 2 KINETIC 2 dose-range study of SAGE-324 (BIIB124) as a potential treatment for essential tremor (ET). The KINETIC 2 Study did not demonstrate a statistically significant dose-response relationship in change from baseline to Day 91 based on the primary endpoint, The Essential Tremor...
Remy Cointreau too concentrated in cognac, investors say
Remy Cointreau too concentrated in cognac, investors say
Jul 24, 2024
LONDON (Reuters) - Remy Cointreau investors say the company needs to diversify further as its reliance on cognac sales in the United States and China leaves it among the worst-hit by a global spirits downturn. The maker of Remy Martin cognac has already signalled it wants to grow sales in other markets and invest in its portfolio of other drinks,...
-- New Gold Brief: Reporting Fatality at the Rainy River Mine
-- New Gold Brief: Reporting Fatality at the Rainy River Mine
Jul 24, 2024
11:15 AM EDT, 07/24/2024 (MT Newswires) -- Price: 3.14, Change: +0.11, Percent Change: +3.63 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved